The modulation of MSC integrin expression by RGD presentation

Biomaterials

Volumn 34, Issue 16, 2013, Pages 3938-3947

  Lam, Jonathan ^a   Segura, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hyaluronic acid; Hydrogel; Mesenchymal stem cells; RGD clustering

Indexed keywords

DESIGN PARAMETERS; ENCAPSULATED CELL; HYALURONIC ACID HYDROGELS; MESENCHYMAL STEM CELL; NATIVE EXTRACELLULAR MATRIX; RGD CLUSTERING; SIGNAL DISTRIBUTION; SIGNIFICANT DIFFERENCES;

ADHESION; BIOMATERIALS; BIOMECHANICS; CELL CULTURE; CELLS; HYALURONIC ACID; HYDROGELS; LARGE SCALE SYSTEMS; MECHANICAL PROPERTIES; ORGANIC ACIDS; PEPTIDES; TISSUE;

BEHAVIORAL RESEARCH;

HYALURONIC ACID; INTEGRIN; PROTEIN; PROTEIN RGD; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL SPREADING; CONTROLLED STUDY; ENCAPSULATION; HYDROGEL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HYDROGEL; INTEGRINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MECHANICAL PHENOMENA; MESENCHYMAL STROMAL CELLS; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN SUBUNITS; TIME FACTORS;

EID: 84874955760     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.091     Document Type: Article

References (67)

1. Weigelt B., Bissell M.J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol 2008, 18:311-321.
2. LaBarge M.A., Petersen O.W., Bissell M.J. Of microenvironments and mammary stem cells. Stem Cell Rev 2007, 3:137-146.
3. Nelson C.M., Bissell M.J. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2006, 22:287-309.
4. Hagios C., Lochter A., Bissell M.J. Tissue architecture: the ultimate regulator of epithelial function?. Philos Trans R Soc Lond Ser B-Biol Sci 1998, 353:857-870.
5. Boudreau N., Bissell M.J. Extracellular matrix signaling: integration of form and function in normal and malignant cells. Curr Opin Cell Biol 1998, 10:640-646.
6. Bissell M.J., Hall H.G., Parry G. How does the extracellular-matrix direct gene-expression. J Theor Biol 1982, 99:31-68.
7. Cosgrove B.D., Sacco A., Gilbert P.M., Blau H.M. A home away from home: challenges and opportunities in engineering in vitro muscle satellite cell niches. Differentiation 2009, 78:185-194.
8. Lutolf M.P., Blau H.M. Artificial stem cell niches. Adv Mater 2009, 21:3255-3268.
9. Lutolf M.P., Doyonnas R., Havenstrite K., Koleckar K., Blau H.M. Perturbation of single hematopoietic stem cell fates in artificial niches. Integr Biol 2009, 1:59-69.
10. Bissell M.J., Hines W.C. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011, 17:320-329.
11. Bissell M.J., LaBarge M.A. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?. Cancer Cell. 2005, 7:17-23.
12. Ghajar C.M., Bissell M.J. Tumor engineering: the other face of tissue engineering. Tissue Eng Part A 2010, 16:2153-2156.
13. Nelson C.M., Bissell M.J. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin Cancer Biol 2005, 15:342-352.
14. Park C.C., Bissell M.J., Barcellos-Hoff M.H. The influence of the microenvironment on the malignant phenotype. Mol Med Today 2000, 6:324-329.
15. Petersen O.W., Nielsen H.L., Gudjonsson T., Villadsen R., Ronnov-Jessen L., Bissell M.J. The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001, 3:213-217.
16. Radisky D., Hagios C., Bissell M.J. Tumors are unique organs defined by abnormal signaling and context. Semin Cancer Biol 2001, 11:87-95.
17. Ronnov-Jessen L., Bissell M.J. Breast cancer by proxy: can the microenvironment be both the cause and consequence?. Trends Mol Med 2009, 15:5-13.
18. Turley E.A., Veiseh M., Radisky D.C., Bissell M.J. Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression?. Nat Clin Pract Oncol 2008, 5:280-290.
19. Xu R., Boudreau A., Bissell M. Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices. Cancer Metastasis Rev 2009, 28:167-176.
20. Moon J.J., Saik J.E., Poche R.A., Leslie-Barbick J.E., Lee S.H., Smith A.A., et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010, 31:3840-3847.
21. Phelps EA, Landazuri N, Thule PM, Taylor WR, Garcia AJ. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 107:3323-8.
22. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. Faseb J 2003, 17:2260-2262.
23. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 2001, 72:101-113.
24. Anderson S.M., Shergill B., Barry Z.T., Manousiouthakis E., Chen T.T., Botvinick E., et al. VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF. Integr Biol (Camb) 2011, 3:887-896.
25. Peppas N.A., Hilt J.Z., Khademhosseini A., Langer R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv Mater 2006, 18:1345-1360.
26. Kopecek J., Yang J.Y. Review - hydrogels as smart biomaterials. Polym Int 2007, 56:1078-1098.
27. Tibbitt M.W., Anseth K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 2009, 103:655-663.
28. Lei Y.G., Gojgini S., Lam J., Segura T. The spreading, migration and proliferation of mouse mesenchymal stem cells cultured inside hyaluronic acid hydrogels. Biomaterials 2011, 32:39-47.
29. Butcher J.T., Nerem R.M. Porcine aortic valve interstitial cells in three-dimensional culture: comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis 2004, 13:478-485.
30. Eyrich D., Brandl F., Appel B., Wiese H., Maier G., Wenzel M., et al. Long-term stable fibrin gels for cartilage engineering. Biomaterials 2007, 28:55-65.
31. Azab A.K., Orkin B., Doviner V., Nissan A., Klein M., Srebnik M., et al. Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis. J Control Release 2006, 111:281-289.
32. Barralet J.E., Wang L., Lawson M., Triffitt J.T., Cooper P.R., Shelton R.M. Comparison of bone marrow cell growth on 2D and 3D alginate hydrogels. J Mater Sci Mater Med 2005, 16:515-519.
33. Adeloew C., Segura T., Hubbell J.A., Frey P. The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials 2008, 29:314-326.
34. Nuttelman C.R., Henry S.M., Anseth K.S. Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. Biomaterials 2002, 23:3617-3626.
35. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324:1673-1677.
36. Lutolf M.P., Gilbert P.M., Blau H.M. Designing materials to direct stem-cell fate. Nature 2009, 462:433-441.
37. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
38. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Bi 1996, 12:697-715.
39. Kibbey M.C., Jucker M., Weeks B.S., Neve R.L., Vannostrand W.E., Kleinman H.K. Beta-amyloid precursor protein binds to the neurite-promoting Ikvav site of laminin. Proc Natl Acad Sci U S A 1993, 90:10150-10153.
40. Nomizu M., Weeks B.S., Weston C.A., Kim W.H., Kleinman H.K., Yamada Y. Structure-activity study of a laminin alpha-1 chain active peptide segment Ile-Lys-Val-Ala-Val (Ikvav). Febs Lett 1995, 365:227-231.
41. Maeda T., Titani K., Sekiguchi K. Cell-adhesive activity and receptor-binding specificity of the laminin-derived Yigsr sequence grafted onto staphylococcal protein-A. J Biochem-Tokyo 1994, 115:182-189.
42. Giancotti F.G., Ruoslahti E. Integrin signaling. Science (New York, NY) 1999, 285:1028-1032.
43. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science (New York, NY) 2001, 294:1708-1712.
44. Jones J.L., Walker R.A. Integrins: a role as cell signalling molecules. J Clin Pathol Mol Pa 1999, 52:208-213.
45. Prowse A.B.J., Chong F., Gray P.P., Munro T.P. Stem cell integrins: Implications for ex-vivo culture and cellular therapies. Stem Cell Res 2011, 6:1-12.
46. Davis G.E., Senger D.R. Endothelial extracellular matrix - biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005, 97:1093-1107.
47. Hood J.D., Cheresh D.A. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002, 2. 91.
48. Comisar W.A., Kazmers N.H., Mooney D.J., Linderman J.J. Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials 2007, 28:4409-4417.
49. Comisar W.A., Mooney D.J., Linderman J.J. Integrin organization: linking adhesion ligand nanopatterns with altered cell responses. J Theor Biol 2011, 274:120-130.
50. Maheshwari G., Brown G., Lauffenburger D.A., Wells A., Griffith L.G. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 2000, 113:1677-1686.
51. Koo L.Y., Irvine D.J., Mayes A.M., Lauffenburger D.A., Griffith L.G. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J Cell Sci 2002, 115:1423-1433.
52. Lee K.Y., Alsberg E., Hsiong S., Comisar W., Linderman J., Ziff R., et al. Nanoscale adhesion ligand organization regulates osteoblast proliferation and differentiation. Nano Lett 2004, 4:1501-1506.
53. Kong H.J., Hsiong S., Mooney D.J. Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression. Nano Lett 2007, 7:161-166.
54. Alsberg E., Anderson K.W., Albeiruti A., Franceschi R.T., Mooney D.J. Cell-interactive alginate hydrogels for bone tissue engineering. J Dental Res 2001, 80:2025-2029.
55. Lutolf M.P., Lauer-Fields J.L., Schmoekel H.G., Metters A.T., Weber F.E., Fields G.B., et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A 2003, 100:5413-5418.
56. Allison D.D., Grande-Allen K.J. Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng 2006, 12:2131-2140.
57. Fraser J.R.E., Laurent T.C., Laurent U.B.G. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 1997, 242:27-33.
58. Diduch D.R., Coe M.R., Joyner C., Owen M.E., Balian G. 2 cell-lines from bone-marrow that differ in terms of collagen-synthesis, osteogenic characteristics, and matrix mineralization. J Bone Jt Surg Am 1993, 75A:92-105.
59. Li X.D., Cui Q.J., Kao C.H., Wang G.J., Balian G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPAR gamma 2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 2003, 33:652-659.
60. Li X.D., Jin L., Cui Q.J., Wang G.J., Balian G. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 2005, 16:101-108.
61. Devine M.J., Mierisch C.M., Jang E., Anderson P.C., Balian G. Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res 2002, 20:1232-1239.
62. Weissman I.L. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000, 100:157-168.
63. Donovan P.J., Gearhart J. The end of the beginning for pluripotent stem cells. Nature 2001, 414:92-97.
64. Fuchs E., Segre J.A. Stem cells: a new lease on life. Cell. 2000, 100:143-155.
65. Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp Biol Med 2001, 226:507-520.
66. Discher D.E., Sweeney L., Sen S., Engler A. Matrix elasticity directs stem cell lineage specification. Biophysical J 2007, 32a-a.
67. Huebsch N., Arany P.R., Mao A.S., Shvartsman D., Ali O.A., Bencherif S.A., et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 2010, 9:518-526.